Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, ...

Craft Capital Management LLC acted as underwriter for the Offering (the “Underwriter”). VCL Law LLP acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. securities ...

Tainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis ...

Advanced Biomed Inc. (ADVB) expects to raise $10 million in an initial public offering (IPO) on the week of February 24th, IPO Scoop reports. The company will be issuing 1,900,000 shares at $4.00 ...

DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the ...

Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Detailed price information for Clearside Biomedi (CLSD-Q) from The Globe and Mail including charting and trades.

Mr. Dawes will be joined at the conference by Dr. Rachel Brem, board member and part-time Chief Medical Officer, and Jean Nadeau, Chairman. Centurion One Capital 8th Annual Growth Conference ...

The global meningitis treatment industry, valued at USD 150.9 million in 2023, is projected to grow at a CAGR of 4.1% from ...

Q4 2024 Earnings Call Transcript March 4, 2025 InfuSystem Holdings, Inc. misses on earnings expectations. Reported EPS is ...